Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sharon E Kim & Edy Soffer. (2016) Electrical stimulation for gastroesophageal reflux disease: current state of the art. Clinical and Experimental Gastroenterology 9, pages 11-19.
Read now
Read now
Hiroto Miwa, Tomomi Takeshima, Kosuke Iwasaki & Shinzo Hiroi. (2016) Medical cost, incidence rate, and treatment status of gastroesophageal reflux disease in Japan: analysis of claims data. Journal of Medical Economics 19:11, pages 1049-1055.
Read now
Read now
Catarina Jansson, Michael Wiberg & Kristina Alexanderson. (2013) Sickness absence due to gastroesophageal reflux diagnoses: a nationwide Swedish population-based study. Scandinavian Journal of Gastroenterology 48:1, pages 17-26.
Read now
Read now
Jung Mook Kang, Pyoung Ju Seo, Nayoung Kim, Byoung Hwan Lee, Jinweon Kwon, Dong Ho Lee & Hyun Chae Jung. (2012) Analysis of direct medical care costs of peptic ulcer disease in a Korean tertiary medical center. Scandinavian Journal of Gastroenterology 47:1, pages 36-42.
Read now
Read now
Jan-Samuel Wagner, Marco daCosta DiBonaventura, Sanjeev Balu & Deborah Buchner. (2011) The burden of diurnal and nocturnal gastroesophageal reflux disease symptoms. Expert Review of Pharmacoeconomics & Outcomes Research 11:6, pages 739-749.
Read now
Read now
Articles from other publishers (49)
Shien Shen, Ge Yu, Xingya Guo, Guanzhao Zong, Chuanyang Wang, Jingpiao Bao, Jiahui Chen, Zhiyuan Cheng, Wenqin Xiao, Jie Shen, Weiliang Jiang & Rong Wan. (2023) The long-term efficacy of transoral incisionless fundoplication with Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease. Esophagus 20:3, pages 581-586.
Crossref
Crossref
Prateek Sharma, Gary W. Falk, Menaka Bhor, A. Burak Ozbay, Dominick Latremouille-Viau, Annie Guerin, Sherry Shi, Margaret M. Elvekrog & Paul Limburg. (2023) Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States. Journal of Health Economics and Outcomes Research 10:1.
Crossref
Crossref
Armin Abadeh, Sari M. Herman & Rupert Abdalian. (2023) The prevalence of gastrointestinal symptoms and cobalamin deficiency in patients with chronic urticaria. Allergy, Asthma & Clinical Immunology 19:1.
Crossref
Crossref
Prateek Sharma, Gary Falk, Menaka Bhor, A. Burak Ozbay, Dominick Latremouille-Viau, Annie Guerin, Sherry Shi, Margaret Elvekrog & Paul Limburg. (2023) Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States. Journal of Health Economics and Outcomes Research, pages 51-58.
Crossref
Crossref
Zhuolin Zhang, Yuwen Bao, Lele Cai, Yajie Gu, Ting Yang & Xin Li. (2022) Cost-Utility Analysis of CYP2C19 Genotype Detection for Selection of Acid-Suppressive Therapy with Lansoprazole or Vonoprazan for Patients with Reflux Esophagitis in China. Clinical Drug Investigation 42:10, pages 839-851.
Crossref
Crossref
Chunping Yu, Yang Gao, Xin Wang, Rui Zhang, Nana Liu, Zhenji Rong, Zhigang Wang, Jing Yang, Miaoqin Xie, Hailong Zhang & He Bao. (2022) The chemical constituents and gastroprotective effects of Calanthe fimbriata Franch. Biomedicine & Pharmacotherapy 153, pages 113468.
Crossref
Crossref
Jiatian Li, Na Lu, Houchen Lyu, Guanghua Lei, Chao Zeng, Jie Wei, Yilun Wang & Dongxing Xie. (2022) Peptic Ulcer Disease and Risk of Hip Fracture: A General Population-based Cohort Study. The Journal of Clinical Endocrinology & Metabolism 107:9, pages e3738-e3746.
Crossref
Crossref
Xiaohua Hou, Fandong Meng, Jiangbin Wang, Weihong Sha, Cheng‐Tang Chiu, Woo Chul Chung, Liqun Gu, Kentarou Kudou, Chui Fung Chong & Shutian Zhang. (2022)
Vonoprazan non‐inferior to lansoprazole in treating duodenal ulcer and eradicating
Helicobacter pylori
in Asian patients
. Journal of Gastroenterology and Hepatology 37:7, pages 1275-1283.
Crossref
Crossref
Simon C. Mathews, Sergey Izmailyan, Frances A. Brito, Jose-Miguel Yamal, Osama Mikhail & Frances L. Revere. (2022) Prevalence and Financial Burden of Digestive Diseases in a Commercially Insured Population. Clinical Gastroenterology and Hepatology 20:7, pages 1480-1487.e7.
Crossref
Crossref
Bo Zou, Chaofan Cao, Yue Fu, Dianzhu Pan, Wei Wang & Lingfei Kong. (2022) Berberine Alleviates Gastroesophageal Reflux-Induced Airway Hyperresponsiveness in a Transient Receptor Potential A1-Dependent Manner. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-14.
Crossref
Crossref
Andreas Lynen, Meike Schömitz, Maik Vahle, Anne Jäkel, Michaela Rütz & Florian Schwerla. (2022) Osteopathic treatment in addition to standard care in patients with Gastroesophageal Reflux Disease (GERD) – A pragmatic randomized controlled trial. Journal of Bodywork and Movement Therapies 29, pages 223-231.
Crossref
Crossref
Yori Yuliandra, Lili Fitriani, Robby Kurniawan, Fuji Yasardi & Erizal Zaini. (2020) Solid Dispersions of Famotidine: Physicochemical Properties and In Vivo Comparative Study on the Inhibition of Hyperacidity. ChemistrySelect 5:29, pages 9218-9225.
Crossref
Crossref
Kara L. Raphael, Patrick Walsh & Petros C. Benias. (2020) Innovations in Endoscopic Therapy for Gastroesophageal Reflux Disease. Gastrointestinal Endoscopy Clinics of North America 30:2, pages 291-307.
Crossref
Crossref
Domenico Ventrella, Roberta SalaroliAlberto Elmi, Giacomo CarnevaliMonica Forni, Fabio Baldi & Maria Laura Bacci. (2020) A novel ex vivo porcine model of acid-induced esophageal damage for preliminary functional evaluations of anti-gastroesophageal reflux disease medical devices. Veterinary World 13:12, pages 2728-2735.
Crossref
Crossref
Hirota Miyazaki, Ataru Igarashi, Toshihisa Takeuchi, Lida Teng, Akihito Uda, Hisato Deguchi, Kazuhide Higuchi & Toshiro Tango. (2019)
Vonoprazan
versus
proton‐pump inhibitors for healing gastroesophageal reflux disease: A systematic review
. Journal of Gastroenterology and Hepatology.
Crossref
Crossref
Scott Klenzak, Igor Danelisen, Grace D Brannan, Melissa A Holland & Miranda AL van Tilburg. (2018) Management of gastroesophageal reflux disease: Patient and physician communication challenges and shared decision making. World Journal of Clinical Cases 6:15, pages 892-900.
Crossref
Crossref
Menizibeya Osain WelcomeMenizibeya Osain Welcome. 2018. Gastrointestinal Physiology. Gastrointestinal Physiology
991
1007
.
Francisco Schlottmann, Fernando A. Herbella, Marco E. Allaix, Fabrizio Rebecchi & Marco G. Patti. (2017) Surgical Treatment of Gastroesophageal Reflux Disease. World Journal of Surgery 41:7, pages 1685-1690.
Crossref
Crossref
Mariano A. Menezes & Fernando A. M. Herbella. (2017) Pathophysiology of Gastroesophageal Reflux Disease. World Journal of Surgery 41:7, pages 1666-1671.
Crossref
Crossref
W. F. W. Kappelle, A. J. Bredenoord, J. M. Conchillo, J. P. Ruurda, N. D. Bouvy, M. I. van Berge Henegouwen, P. W. Chiu, M. Booth, A. Hani, D. N. Reddy, A. Bogte, A. J. P. M. Smout, J. C. Wu, A. Escalona, M. A. Valdovinos, G. Torres-Villalobos & P. D. Siersema. (2015) Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease - interim results of an international multicentre trial. Alimentary Pharmacology & Therapeutics 42:5, pages 614-625.
Crossref
Crossref
Jessica Weakley, Mayris P. Webber, Fen Ye, Rachel Zeig-Owens, Hillel W. Cohen, Charles B. Hall, Kerry Kelly & David J. Prezant. (2014) Agreement between upper respiratory diagnoses from self-report questionnaires and medical records in an occupational health setting. American Journal of Industrial Medicine 57:10, pages 1181-1187.
Crossref
Crossref
Joel H. Rubenstein & Joan W. Chen. (2014) Epidemiology of Gastroesophageal Reflux Disease. Gastroenterology Clinics of North America 43:1, pages 1-14.
Crossref
Crossref
Wei-Ping Bi. (2014) Efficacy and safety of herbal medicines in treating gastric ulcer: A review. World Journal of Gastroenterology 20:45, pages 17020.
Crossref
Crossref
R. C. V. da Silva, C. C. de Sá, Á. O. Pascual-Vaca, L. H. de Souza Fontes, F. A. M. Herbella Fernandes, R. A. Dib, C. R. Blanco, R. A. Queiroz & T. Navarro-Rodriguez. (2013) Increase of lower esophageal sphincter pressure after osteopathic intervention on the diaphragm in patients with gastroesophageal reflux. Diseases of the Esophagus 26:5, pages 451-456.
Crossref
Crossref
Hyun Jin Song, Jin-Won Kwon, Nayoung Kim & Young Soo Park. (2013) Cost Effectiveness Associated with Helicobacter pylori Screening and Eradication in Patients Taking Nonsteroidal Anti-Inflammatory Drugs and/or Aspirin. Gut and Liver 7:2, pages 182-189.
Crossref
Crossref
Antoni Sicras-Mainar, Ruth Navarro-Artieda & Jordi Ibáñez-Nolla. (2013) Resource Use and Economic Impact of Patients With Gout: A Multicenter, Population-Wide Study. Reumatología Clínica (English Edition) 9:2, pages 94-100.
Crossref
Crossref
Antoni Sicras-Mainar, Ruth Navarro-Artieda & Jordi Ibáñez-Nolla. (2013) Uso de recursos e impacto económico de los pacientes con gota: estudio multicéntrico de ámbito poblacional. Reumatología Clínica 9:2, pages 94-100.
Crossref
Crossref
J. Zeidler, A. Lange, S. Braun, R. Linder, S. Engel, F. Verheyen & J.-M. Graf von der Schulenburg. (2013) Die Berechnung indikationsspezifischer Kosten bei GKV-Routinedatenanalysen am Beispiel von ADHSCalculation of disease-related costs in claims data analyses with the example of attention-deficit hyperactivity disorder. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 56:3, pages 430-438.
Crossref
Crossref
Junjie Xu, Minyue Tang & Jun Shen. (2013) Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade. Gastroenterology Research and Practice 2013, pages 1-12.
Crossref
Crossref
Romy Steenbeek. (2012) The importance of job characteristics in determining medical care-seeking in the Dutch working population, a longitudinal survey study. BMC Health Services Research 12:1.
Crossref
Crossref
Shijie Ma, Bingbing Qian, Li Shang, Ruihua Shi & Guoxin Zhang. (2012) A meta-analysis comparing laparoscopic partial versus Nissen fundoplication. ANZ Journal of Surgery 82:1-2, pages 17-22.
Crossref
Crossref
Javier Nuevo, Mónica Tafalla, Javier Zapardiel & JP Gisbert. (2011) Consumo de recursos sanitarios y pérdida de productividad en la enfermedad por reflujo gastroesofágico: resultados de un estudio transversal en el ámbito de la atención primaria en España. Atención Primaria 43:9, pages 474-481.
Crossref
Crossref
Bijan Moghimi-Dehkordi, Mohsen Vahedi, Babak Khoshkrood Mansoori, Amir Kasaeian, Azadeh Safaee, Manijeh Habibi, Asma Pourhoseingholi, Mohammad Amin Pourhoseingholi & Mohammad Reza Zali. (2011) Economic burden of gastro-oesophageal reflux disease and dyspepsia: A community-based study. Arab Journal of Gastroenterology 12:2, pages 86-89.
Crossref
Crossref
Rafael Corrêa Vieira da Silva, Tomás Navarro-Rodríguez, Ángel Oliva Pascual-Vaca & Cleofás Rodríguez Blanco. (2010) La enfermedad por ref ujo gastroesofágico y la unión esofagogástrica. Revisión de la literatura. Osteopatía Científica 5:3, pages 84-88.
Crossref
Crossref
Jun Su, Richard A. Brook, Nathan L. Kleinman & Patricia Corey-Lisle. (2010) The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs. Hepatology 52:2, pages 436-442.
Crossref
Crossref
Pyoung Ju Seo, Nayoung Kim, Jane C Oh, Byoung Hwan Lee, Cheol Min Shin, Seungchul Suh, Hyunkyung Park, Ryoung Hee Nam, Jin A Cha, Young Soo Park & Dong Ho Lee. (2010) Comparison of Direct Medical Care Costs Between Erosive Reflux Disease and Non-erosive Reflux Disease in Korean Tertiary Medical Center. Journal of Neurogastroenterology and Motility 16:3, pages 291-298.
Crossref
Crossref
Richard A. Brook, Nathan L. Kleinman, Rok Seon Choung, Arthur K. Melkonian, James E. Smeeding & Nicholas J. Talley. (2010) Functional Dyspepsia Impacts Absenteeism and Direct and Indirect Costs. Clinical Gastroenterology and Hepatology 8:6, pages 498-503.
Crossref
Crossref
Alan Barkun & Grigorios Leontiadis. (2010) Systematic Review of the Symptom Burden, Quality of Life Impairment and Costs Associated with Peptic Ulcer Disease. The American Journal of Medicine 123:4, pages 358-366.e2.
Crossref
Crossref
Gilman B. Allen, Timothy R. Leclair, Jessica von Reyn, Yuna C. Larrabee, Mary E. Cloutier, Charles G. Irvin & Jason H. T. Bates. (2009) Acid aspiration-induced airways hyperresponsiveness in mice. Journal of Applied Physiology 107:6, pages 1763-1770.
Crossref
Crossref
Marlís González-Fernández, Michael Gardyn, Shamolie Wyckoff, Paul K. S. Ky & Jeffrey B. Palmer. (2009) Validation of ICD-9 Code 787.2 for Identification of Individuals with Dysphagia from Administrative Databases. Dysphagia 24:4, pages 398-402.
Crossref
Crossref
John Birk, Ronald Pruitt, Gregory Haber, Isaac Raijman, Arthur Baluyut, Mick Meiselman & Shahriar Sedghi. (2008) The Plicator procedure for the treatment of gastroesophageal reflux disease: a registry study. Surgical Endoscopy 23:2, pages 423-431.
Crossref
Crossref
Ravishankar JayadevappaSumedha Chhatre & Mark Weiner. (2008) Gastro-oesophageal acid-related disease, co-morbidity and medical care cost. Chronic Illness 4:3, pages 209-218.
Crossref
Crossref
Roopa Vemulapalli. (2008) Diet and Lifestyle Modifications in the Management of Gastroesophageal Reflux Disease. Nutrition in Clinical Practice 23:3, pages 293-298.
Crossref
Crossref
M. Rezailashkajani, D. Roshandel, S. Shafaee & M.R. Zali. (2008) A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran. Digestive and Liver Disease 40:6, pages 412-417.
Crossref
Crossref
Peter Wahlqvist, Richard A. Brook, Sara M. Campbell, Mari-Ann Wallander, Anne M. Alexander, Jim E. Smeeding & Nathan L. Kleinman. (2008) Objective Measurement of Work Absence and On-The-Job Productivity: A Case-Control Study of US Employees With and Without Gastroesophageal Reflux Disease. Journal of Occupational & Environmental Medicine 50:1, pages 25-31.
Crossref
Crossref
R. A. BROOK, P. WAHLQVIST, N. L. KLEINMAN, M.-A. WALLANDER, S. M. CAMPBELL & J. E. SMEEDING. (2007) Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States. Alimentary Pharmacology & Therapeutics 26:6, pages 889-898.
Crossref
Crossref
Romy Steenbeek & Jan Fekke Ybema. (2007) De relatie tussen medische consumptie en verzuim bij personeel van een groot ziekenhuis. TSG 85:6, pages 337-344.
Crossref
Crossref
Alvaro Reymunde & Nilda Santiago. (2007) Long-term results of radiofrequency energy delivery for the treatment of GERD: sustained improvements in symptoms, quality of life, and drug use at 4-year follow-up. Gastrointestinal Endoscopy 65:3, pages 361-366.
Crossref
Crossref
Edoardo G. Giannini, Patrizia Zentilin, Pietro Dulbecco, Elena Iiritano, Claudio Bilardi, Edoardo Savarino, Carlo Mansi & Vincenzo Savarino. (2006) A Comparison Between Sodium Alginate and Magaldrate Anhydrous in the Treatment of Patients with Gastroesophageal Reflux Symptoms. Digestive Diseases and Sciences 51:11, pages 1904-1909.
Crossref
Crossref